financetom
Business
financetom
/
Business
/
Calian Announced Normal Course Issuer Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Calian Announced Normal Course Issuer Bid
Sep 1, 2024 7:40 AM

06:26 AM EDT, 08/29/2024 (MT Newswires) -- Calian Group Ltd. ( CLNFF ) , a diverse products and services company trading near 52 week lows, announced overnight Wednesday announced that the Toronto Stock Exchange has accepted a notice filed by the company of its intention to make a normal course issuer bid. In connection with the NCIB, the Company has entered into an automatic share purchase plan with its designated broker to allow for purchases of its common shares.

"We are continuing with a share buyback program as we continue to believe that the market price of the shares does not reflect its underlying value and therefore undervalues the company's future growth prospects," said Kevin Ford, CEO of Calian in a statement. "After three quarters, we are firmly on track with our three-year strategic plan. We have also completed three acquisitions, investing nearly $90 million in capital, all while maintaining a strong balance sheet. We are confident in the long-term prospects of Calian and believe that buying back Shares is a good use of capital."

The notice provides that the company may, during the 12-month period commencing September 1, 2024 and ending August 31, 2025, or on such earlier date as Calian completes its purchases or provides notice of termination, purchase up to 995,904 shares in total, representing approximately 10% of Calian's public float of ahares as at August 16, 2024. As of the close of business on August 16, 2024 the company had 11,846,546 shares issued and outstanding.

Except for block purchases permitted under the rules of the TSX, the number of shares to be purchased per day will not exceed 1,974, which represents 25% of the average daily trading volume of the shares on the TSX for the most recently completed six calendar months (being 7,899 shares) prior to the TSX's acceptance of the Notice. The actual number of shares which may be purchased under the NCIB and the timing of any such purchases will be determined by management of the company, subject to applicable law and the rules of the TSX.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sep 26, 2024
...
Many Wall Street executives are worried about Trump but wary of Harris
Many Wall Street executives are worried about Trump but wary of Harris
Sep 26, 2024
WASHINGTON/NEW YORK (Reuters) - Many Wall Street executives have reservations about backing either candidate in the U.S. presidential election, worried that former President Donald Trump's policies will hurt the economy but wary Vice President Kamala Harris will lean too far left. While multiple Wall Street heavy-hitters including Bill Ackman, John Paulson and George Soros have backed a candidate, many other...
Many Wall Street executives are worried about Trump but wary of Harris
Many Wall Street executives are worried about Trump but wary of Harris
Sep 26, 2024
WASHINGTON/NEW YORK, Sept 27 (Reuters) - Many Wall Street executives have reservations about backing either candidate in the U.S. presidential election, worried that former President Donald Trump's policies will hurt the economy but wary Vice President Kamala Harris will lean too far left. While multiple Wall Street heavy-hitters including Bill Ackman, John Paulson and George Soros have backed a candidate,...
Grifols Among Companies to Face Spanish Regulator's Disciplinary Proceedings
Grifols Among Companies to Face Spanish Regulator's Disciplinary Proceedings
Sep 26, 2024
02:06 PM EDT, 09/25/2024 (MT Newswires) -- Grifols ( GRFS ) is among three companies facing separate disciplinary proceedings initiated by Spain's National Securities Market Commission, the regulator said Wednesday. The Spanish biopharmaceutical firm is facing possible sanctions over alleged inaccuracies and deficiencies in its financial reports, the regulator said. Grifols ( GRFS ) did not immediately respond to MT...
Copyright 2023-2026 - www.financetom.com All Rights Reserved